Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03705572
Other study ID # Arla02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date April 2015

Study information

Verified date October 2018
Source University of Leeds
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Six week RCT intervention on the effects of phospholipid containing milk drink vs. placebo milk drink on cognitive performance in 6-8 year old school children.


Description:

A randomised, double blind, placebo controlled study with parallel groups investigating a 6 week intervention in 6-8 year old school children of phospholipid containing milk drink vs. placebo milk drink. Participants were familiarised with the test battery and IQ (Wechsler abbreviated scale of intelligence) and colour blindness (Ishihara test) measurements were taken prior to the intervention. Milk drink taste testing and milk preference selection was also carried out prior to the intervention. The test battery was administered at baseline (week 0), midpoint (week 3) and endpoint (week 6), and the milk intervention was given Monday - Friday at school shortly before their mid-morning break over a 6 week period. This study design, including both the test days and morning milk supplementation, was intended to emulate the children's normal routine as far as possible. The milk drink was a supplement to the children's usual diet.


Recruitment information / eligibility

Status Completed
Enrollment 165
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 8 Years
Eligibility Inclusion Criteria:

- Male or female, aged 6-8 years.

- Willingness to consume milk drinks during the study determined by a score of >5 on a taste testing Likert scale for at least one flavour of the milk drinks.

- Ability to follow verbal and simple written instructions in English.

- Normal vision, with appropriate corrective lenses if required.

- Ability to understand cognitive testing instructions and responding requirements.

Exclusion Criteria:

- Poor general health.

- Colour blindness.

- Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder).

- Learning disabilities that interfere with the ability to understand written or verbal communications.

- Inability to understand the objective of the cognitive tests, or carry out the tests.

- Any food allergies or intolerances (e.g. lactose intolerance).

- Acute illness, or feelings of unwell, within the week prior to testing.

- Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing.

- Hearing impairment that precludes the ability to follow verbal instructions.

- Children already receiving milk at school unless parents are willing to substitute current milk with the study milk.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Lacprodan PL20
Milk protein concentrate that is high in phospholipid content (min 16%).
Other:
Placebo
Placebo milk drink.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Leeds Arla Foods

Outcome

Type Measure Description Time frame Safety issue
Primary Rivermead Behavioural Memory Test for Children (RBMT-C) change from baseline Test of immediate and delayed verbal memory recall. Week 0, week 3 & week 6
Secondary Motor Screening Task (CANTAB suite) change from baseline To identify motor impairment. Dependent variables: reaction time for each trial and distance from cross. Week 0, week 3 & week 6
Secondary Spatial Recognition Memory (CANTAB suite) change from baseline Dependent variables: number of correct trials and reaction time for each trial. Week 0, week 3 & week 6
Secondary Spatial Span (CANTAB suite) change from baseline Dependent variables: highest span reached, number of correct responses, number of incorrect responses and reaction time for each trial. Week 0, week 3 & week 6
Secondary Reaction time (CANTAB suite) change from baseline Dependent variables: mental reaction time and movement time for each trial, number of correct responses, number of incorrect responses and number of invalid responses. Two parts to the task included simple, one response option, and choice, 5 response options. Week 0, week 3 & week 6
Secondary Subjective mood questionnaire change from baseline Visual Analogue Scale. Week 0, week 3 & week 6
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1